Jared L. Crandon

发表

Unexpected In Vivo Activity of Ceftazidime Alone and in Combination with Avibactam against New Delhi Metallo-β-Lactamase-Producing Enterobacteriaceae in a Murine Thigh Infection Model

D. Nicolau, J. Crandon, S. MacVane, 2014, Antimicrobial Agents and Chemotherapy.

In Vivo Efficacy of Human Simulated Regimens of Carbapenems and Comparator Agents against NDM-1-Producing Enterobacteriaceae

P. Nordmann, D. Nicolau, D. Wiskirchen, 2013, Antimicrobial Agents and Chemotherapy.

Efficacy of Humanized Carbapenem Exposures against New Delhi Metallo-β-Lactamase (NDM-1)-Producing Enterobacteriaceae in a Murine Infection Model

P. Nordmann, D. Nicolau, D. Wiskirchen, 2013, Antimicrobial Agents and Chemotherapy.

Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers

D. Nicolau, J. Crandon, Jared L. Crandon, 2013, Antimicrobial Agents and Chemotherapy.

Poor outcomes of empiric ceftriaxone ± azithromycin for community-acquired pneumonia caused by methicillin-susceptible Staphylococcus aureus

D. Nicolau, J. Crandon, Wonhee So, 2016, Internal and Emergency Medicine.

Newer developments in the treatment of Gram-positive infections

D. Nicolau, J. Crandon, P. Koomanachai, 2009, Expert opinion on pharmacotherapy.

Antibacterial activity of achievable epithelial lining fluid exposures of Amikacin Inhale with or without meropenem.

Y. Hamada, D. Nicolau, J. Crandon, 2016, The Journal of antimicrobial chemotherapy.

Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials

D. Nicolau, David P Nicolau, A. Thabit, 2015, Expert opinion on pharmacotherapy.

Clinical Laboratory–Based Assay Methodologies May Underestimate and Increase Variability of Vancomycin Protein Binding in Hospitalized Patients

D. Nicolau, J. Crandon, S. MacVane, 2014, Pharmacotherapy.

The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms

D. Nicolau, J. Crandon, M. Hagihara, 2012, Expert opinion on drug safety.

Stability of doripenem, imipenem and meropenem at elevated room temperatures.

Christina A. Sutherland, D. Nicolau, J. Crandon, 2011, International journal of antimicrobial agents.

Efficacy of Human Simulated Exposures of Ceftaroline against Phenotypically Diverse Enterobacteriaceae Isolates

D. Nicolau, J. Crandon, R. Keel, 2012, Antimicrobial Agents and Chemotherapy.

In Vivo Efficacy of a Human-Simulated Regimen of Ceftaroline Combined with NXL104 against Extended-Spectrum-β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Enterobacteriaceae

D. Nicolau, D. Wiskirchen, J. Crandon, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy

D. Ehmann, A. Eakin, D. Nicolau, 2015, Antimicrobial Agents and Chemotherapy.

Potentiation of Antibacterial Activity of the MB-1 Siderophore-Monobactam Conjugate Using an Efflux Pump Inhibitor

D. Nicolau, C. McPherson, A. Tomaras, 2015, Antimicrobial Agents and Chemotherapy.

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

D. Nicolau, J. Crandon, C. McPherson, 2013, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and Pulmonary Disposition of Tedizolid and Linezolid in a Murine Pneumonia Model under Variable Conditions

D. Nicolau, J. Crandon, R. Keel, 2012, Antimicrobial Agents and Chemotherapy.

Comparative In Vivo Efficacies of Epithelial Lining Fluid Exposures of Tedizolid, Linezolid, and Vancomycin for Methicillin-Resistant Staphylococcus aureus in a Mouse Pneumonia Model

D. Nicolau, J. Crandon, P. Tessier, 2012, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetics of High-Dose, Prolonged-Infusion Cefepime in Adult Critically Ill Patients with Ventilator-Associated Pneumonia

R. Ariano, D. Nicolau, Aryun Kim, 2009, Antimicrobial Agents and Chemotherapy.

Efficacy of Humanized High-Dose Meropenem, Cefepime, and Levofloxacin against Enterobacteriaceae Isolates Producing Verona Integron-Encoded Metallo-β-Lactamase (VIM) in a Murine Thigh Infection Model

Islam M. Ghazi, E. Lesho, P. McGann, 2015, Antimicrobial Agents and Chemotherapy.

Evaluation of a disease state management guideline for urinary tract infection.

D. Nicolau, M. Nailor, M. Zmarlicka, 2016, International journal of antimicrobial agents.

Cefazolin as a class representative for oral cephalosporins and uncomplicated urinary tract infections caused by indicated Enterobacteriaceae.

Ronald N. Jones, L. Reller, S. Jenkins, 2013, Diagnostic microbiology and infectious disease.

Efficacies of Ceftazidime-Avibactam and Ceftazidime against Pseudomonas aeruginosa in a Murine Lung Infection Model

D. Nicolau, J. Crandon, W. Nichols, 2013, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro and In Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa

Virna J. A. Schuck, D. Nicolau, J. Crandon, 2012, Antimicrobial Agents and Chemotherapy.

Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa

D. Nicolau, J. Crandon, J. Kuti, 2009, Antimicrobial Agents and Chemotherapy.

Efficacy of Human Simulated Exposures of Ceftaroline Administered at 600 Milligrams Every 12 Hours against Phenotypically Diverse Staphylococcus aureus Isolates

D. Nicolau, J. Crandon, R. Keel, 2011, Antimicrobial Agents and Chemotherapy.

Efﬁcacy of Human Simulated Exposures of Ceftaroline Administered at 600 Milligrams Every 12 Hours against Phenotypically Diverse Staphylococcus aureus Isolates (cid:1)

D. Nicolau, J. Crandon, R. Keel, 2011 .